The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...
A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
Thousands of Doctors from across the nation have banded together to support Robert F. Kennedy Jr. to be the next Secretary of the Department of Health and Human ...